NYSE: REXRex American Resources Corp Stock
$34.18+0.06 (+0.18%)
Updated Feb 20, 2026
REX Price
$34.18
Fair Value Price
N/A
Market Cap
$1.13B
52 Week Low
$16.73
52 Week High
$36.50
P/E
22.94x
P/B
1.99x
P/S
1.62x
PEG
5.59x
Dividend Yield
N/A
Revenue
$650.76M
Earnings
$50.30M
Gross Margin
12.7%
Operating Margin
10.42%
Profit Margin
7.7%
Debt to Equity
0.17
Operating Cash Flow
$89M
Beta
0.9
Next Earnings
Mar 26, 2026
Ex-Dividend
N/A
Next Dividend
N/A
REX Overview
Rex American Resources Corporation produces and sells ethanol in the U.S. It also offers corn, distillers grains, non-food grade corn oil, gasoline, and natural gas. Formerly Rex Stores Corp., Rex American Resources was founded in 1980 and is headquartered in Dayton, OH.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine REX's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Chemical
Industry Rating
D
REX
Ranked#4 of 14
Ranked#4 of 14
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $21.21 | A | |
| $14.02 | B | |
| $10.04 | B |
Be the first to know about important REX news, forecast changes, insider trades & much more!
REX News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how REX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
REX ($34.18) is trading above its intrinsic value of $11.03, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
REX is good value based on its earnings relative to its share price (22.94x), compared to the US market average (44.63x)
P/E vs Market Valuation
REX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more REX due diligence checks available for Premium users.
Valuation
REX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
22.94x
Industry
-19.88x
Market
44.63x
REX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
REX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
REX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.99x
Industry
1.37x
REX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
REX price to earnings growth (PEG)
For valuing profitable companies with growth potential
REX is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
REX's financial health
Profit margin
Revenue
$175.6M
Net Income
$23.4M
Profit Margin
13.3%
REX's Earnings (EBIT) of $67.82M... subscribe to Premium to read more.
Interest Coverage Financials
REX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$750.1M
Liabilities
$93.9M
Debt to equity
0.17
REX's short-term assets ($411.66M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
REX's short-term assets ($411.66M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
REX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
REX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$51.2M
Investing
-$20.1M
Financing
-$119.0k
REX's operating cash flow ($89.13M)... subscribe to Premium to read more.
Debt Coverage Financials
REX vs Chemical Stocks
Rex American Resources Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.